Newmark Appointed as Exclusive Leasing Agent for Taystee Lab Building in Innovation Triangle-West Harlem

September 24, 2024 9:00 AM

Newmark announces it has been named the exclusive leasing agent for the Taystee Lab Building in New York City. Newmark Executive Managing Director Jonathan Fanuzzi, Senior Managing Director Jordan Gosin, Director Chris Ventura and Associate Leo Koné will represent property owners Janus Property Company and institutional investors advised by J.P. Morgan Asset Management.

“The Taystee Lab Building is the only new, ground-up, purpose-built commercial life sciences building in New York with multiple occupancy options,” said Fanuzzi. “The Janus Property Company and J.P. Morgan Asset Management have custom-designed and expertly engineered this building to offer maximum flexibility and efficiency in layout.”

The 350,000-square-foot, 11-story LEED Silver-certified life science property offers state-of-the-art features specifically tailored and built for the life sciences, material sciences, climate sciences and engineering communities. The building features 100% floor-to-ceiling curtain wall glazing that provides stunning views on three sides, while laboratories are shielded from all but northern sun exposure. Additional amenities include an indoor bike room, private outdoor terraces on half the floors, and two lobbies.

The property is in Innovation Triangle-West Harlem, a growing, world-class life sciences ecosystem surpassing most other areas in New York City. The Triangle connects the Janus Property Company Factory District with Columbia University and the CUNY Advanced Science Research Center/City College of New York campuses.

The Triangle already contains prominent for-profit and not-for-profit institutions such as the New York Structural Biology Center, Volastra Therapeutics, BioBus, Quicksilver Therapeutics, Renal Research Institute, Hypothekids, Harlem Biospace, Hemogenyx Pharmaceuticals, Jerome L. Greene Science Center/Zuckerman Mind Brain Behavior Institute, Fu School of Engineering and soon, the Chan Zuckerberg Initiative. Additionally, the Innovation Triangle is two short stops on the subway to New York-Presbyterian Columbia University Irving Medical Center/Vagelos College of Physicians & Surgeons.

The area includes the A/C, B/D and #1 125th Street subway stations, the Express Bus to LaGuardia Airport, and a Citibike station. It is also a short walk or Express Bus ride to MetroNorth on Park Avenue. It offers immediate access to the West Side Highway and George Washington Bridge, connecting New Jersey’s and Upstate New York’s major pharmaceutical companies.

About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries (“Newmark”), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark’s comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform’s global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. For the year ended December 31, 2023, Newmark generated revenues of approximately $2.5 billion. As of June 30, 2024, Newmark’s company-owned offices, together with its business partners, operate from approximately 170 offices with 7,800 professionals around the world. To learn more, visit nmrk.com or follow @newmark.

Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company’s business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.